Suppr超能文献

甲氨蝶呤接枝寡聚壳聚糖胶束作为药物载体:合成与生物学评价

Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations.

作者信息

Fattahi Ali, Asgarshamsi Mohammadhossein, Hasanzadeh Farshid, Varshosaz Jaleh, Rostami Mahbobeh, Mirian Mina, Sadeghi-aliabadi Hojjat

机构信息

Medical Biology Research Center, Kermanshah University of Medical Sciences, 6734667149, Kermanshah, Iran.

出版信息

J Mater Sci Mater Med. 2015 Feb;26(2):119. doi: 10.1007/s10856-015-5407-5. Epub 2015 Feb 13.

Abstract

The novel amphiphilic derivatives of Methotrexate-chitosan oligosaccharide (MTX-CHO) with different molar feeding ratios of MTX were synthesized. The degree of MTX substitution ranged from 4.47 to 13.5%. MTX-CHO copolymer formed micelles with an average size of 134.6±14.52 to 236.6±30.01 nm, and zeta potential of 20±5 to 16.8±7.74 mV. The critical micelle concentration was found to range from 125 to 0.56 mg/l. Analysis of micelles with different degree of substitutions (DSs) revealed that the size of micelles decreased by increasing DS while zeta potential was reduced. Release study indicated that drug content had effect on the release rate. With increasing amount of loaded drug in the micelle, release rate was decreased. Drug loaded and unloaded MTX-CHO micelles showed significant cytotoxicity on MDA-MB-231. Loaded micelle was more effective than unloaded one which indicated that conjugation could reduce efficacy of MTX. The viability of MDA-MB-231 in presence of drug loaded micelles was significantly decreased and cell viability at 1 µg/ml was 45.17±9% while the viability of unloaded micelles was 91.86±9.88. These phenomena make MTX-CHO micelles as a good candidate for hydrophobic anticancer drug carrier.

摘要

合成了具有不同甲氨蝶呤(MTX)摩尔投料比的新型甲氨蝶呤-壳寡糖两亲性衍生物(MTX-CHO)。MTX的取代度范围为4.47%至13.5%。MTX-CHO共聚物形成的胶束平均尺寸为134.6±14.52至236.6±30.01 nm,zeta电位为20±5至16.8±7.74 mV。临界胶束浓度范围为125至0.56 mg/l。对不同取代度(DSs)的胶束分析表明,随着DS增加,胶束尺寸减小,而zeta电位降低。释放研究表明药物含量对释放速率有影响。随着胶束中载药量的增加,释放速率降低。载药和未载药的MTX-CHO胶束对MDA-MB-231均显示出显著的细胞毒性。载药胶束比未载药胶束更有效,这表明共轭作用可能会降低MTX的疗效。在载药胶束存在下,MDA-MB-231的活力显著降低,1 µg/ml时的细胞活力为45.17±9%,而未载药胶束的活力为91.86±9.88。这些现象使MTX-CHO胶束成为疏水性抗癌药物载体的良好候选者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验